Ascimib 40 mg Tablet

Brand Name: Ascimib

Molecule: Asciminib

Strength: 40 mg

Quantity: 30 Tablets

Form: Tablet

Packaging Type: Bottle

Manufacturer/Marketed By: Everest Pharma

Country of Origin: Bangladesh

Description

Ascimib Asciminib 40 mg Tablet contains Asciminib, a targeted therapy used to treat Philadelphia chromosome–positive chronic myeloid leukemia (Ph+ CML). It helps control cancer cell growth in patients resistant or intolerant to previous treatments.

Benefits

Targets CML cells with high precision
Effective in patients resistant to multiple TKIs
Helps achieve and maintain molecular remission
Oral therapy for convenient long-term treatment
Lower risk of some TKI-related side effects

Indications and Usage

Ascimib Asciminib 40 mg Tablet is indicated for:

Ph+ Chronic Myeloid Leukemia (CML) — Chronic Phase
Patients previously treated with at least one TKI
Patients resistant or intolerant to prior CML therapies

Therapy must be prescribed and managed by a hematologist/oncologist.

How it Works

Asciminib uniquely targets the ABL myristoyl pocket, blocking BCR-ABL1 signaling responsible for leukemia cell growth. This disrupts cancer cell survival and slows disease progression while sparing healthy cells.